Expertise in
7
conditions

Gordon L. Sussman

Toronto, ON, CA 
Expertise in
7
conditions
Toronto, ON, CA 

Overview

Gordon Sussman practices practicing medicine in Toronto, Canada.

Mr. Sussman is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Chronic Spontaneous Urticaria (CSU), Hives, Angioedema, and Asthma.

He is actively involved in clinical research, co-authoring 100 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Toronto, ON, Canada
Other Locations
Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A 15 Months, Double-Blind, Randomized Controlled Trial Comparing 20 Weeks of Two Dosages of Omalizumab to Placebo to Accelerate a Symptom-driven Oral Immunotherapy Schedule in Subjects Aged 6 to 25 Years With Multiple Food Allergies
A 15 Months, Double-Blind, Randomized Controlled Trial Comparing 20 Weeks of Two Dosages of Omalizumab to Placebo to Accelerate a Symptom-driven Oral Immunotherapy Schedule in Subjects Aged 6 to 25 Years With Multiple Food Allergies
Enrollment Status: Active_not_recruiting
Publish Date: November 27, 2024
Intervention Type: Biological, Other
Study Phase: Phase 2
A One-year Placebo-controlled Phase III Trial Evaluating the Efficacy and Safety of the House Dust Mite (HDM) SLIT-tablet in Children (5-11 Years of Age) With HDM Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma
A One-year Placebo-controlled Phase III Trial Evaluating the Efficacy and Safety of the House Dust Mite (HDM) SLIT-tablet in Children (5-11 Years of Age) With HDM Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma
Enrollment Status: Completed
Publish Date: June 12, 2024
Intervention Type: Biological, Other
Study Drug: Acarizax
Study Phase: Phase 3
An Open-Label, Single-Arm, Historically Controlled, Prospective, Multicenter Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
An Open-Label, Single-Arm, Historically Controlled, Prospective, Multicenter Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
Enrollment Status: Completed
Publish Date: December 09, 2022
Intervention Type: Biological
Study Phase: Phase 3
A Phase 2 Study to Evaluate the Sensitivity, Specificity and Safety of DBV1605, a Ready-to-Use Atopy Patch Test for the Diagnosis of Non-Immunoglobulin E Mediated Cow's Milk Allergy in Children
A Phase 2 Study to Evaluate the Sensitivity, Specificity and Safety of DBV1605, a Ready-to-Use Atopy Patch Test for the Diagnosis of Non-Immunoglobulin E Mediated Cow's Milk Allergy in Children
Enrollment Status: Unknown
Publish Date: August 11, 2022
Intervention Type: Combination product
Study Phase: Phase 2
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Enrollment Status: Completed
Publish Date: February 03, 2021
Intervention Type: Biological
Study Phase: Phase 3
View 4 Less Clinical Trials

100 Total Publications

Lipid-Lowering Medications Increase the Severity of Hymenoptera Venom Anaphylaxis.
Lipid-Lowering Medications Increase the Severity of Hymenoptera Venom Anaphylaxis.
Journal: The journal of allergy and clinical immunology. In practice
Published: April 09, 2026

Frequently Asked Questions about Gordon L. Sussman

Is Gordon L. Sussman a top-rated expert for Chronic Spontaneous Urticaria (CSU)?

MediFind is an objective health platform that identifies experts based on real-world data. Gordon L. Sussman is classified as an Elite expert for Chronic Spontaneous Urticaria (CSU), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Gordon L. Sussman participate in research or clinical trials?

Yes. Gordon L. Sussman has published 100 articles and abstracts on conditions like Chronic Spontaneous Urticaria (CSU). You can view a list of Gordon L. Sussman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Sussman's expertise for a condition
ConditionClose
View All 10 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile